Tim Maughan is Professor of Cancer Studies at the School of Medicine in Cardiff University and an Honorary Consultant Clinical Oncologist at Velindre Hospital specialising in gastrointestinal cancers and lymphoma therapy.
Professor Maughan is the Chair of the NCRI Clinical and Translational Radiotherapy Research Group. The work of this group is broad-ranging in scope and ambitious in intent and aims to enhance radiotherapy related research across the UK.
He is also the Clinical Director of the Wales Cancer Trials Unit, an NCRI accredited and Cancer Research UK core funded unit running a portfolio of major multicentre cancer trials. This Unit grew out of the Wales Cancer Trials Network, a regional clinical trials organisation founded in 1998 by Tim Maughan and colleagues and which was a forerunner of the National Cancer Research Network. Professor Maughan chaired the NCRN operational steering group from 2005-7. He is the Clinical Director of the Clinical Research Collaboration Cymru Coordinating Centre. This major research collaboration funded by the Wales Assembly Government aims to develop an internationally competitive infrastructure for clinical research in health and social care and is the Welsh component of the UK Clinical Research Network.
Professor Maughan's research is in the treatment of patients with colorectal cancer. He is the Chief Investigator of the MRC COIN trial, evaluating novel treatments in metastatic colorectal cancer, and of the MRC FOCUS 3 trial evaluating the feasibility of molecular selection of therapy in metastatic colorectal cancer. There is an extensive translational research programme running alongside the COIN and FOCUS 3 trials, much of which is centred in Cardiff. He has previously worked in University College London, Southern Sudan and Cambridge.